What is the initial approach to evaluating a patient presenting with insomnia?

Initial Evaluation of Insomnia

Begin by conducting a structured clinical interview that specifically characterizes the sleep complaint pattern (difficulty falling asleep, staying asleep, or early morning awakening), quantifies daytime impairment, and systematically screens for comorbid conditions that commonly perpetuate insomnia 1.

Core Sleep History Components

Your initial assessment must capture these specific elements:

Sleep Pattern Characterization

• Exact timing: Bedtime, sleep onset latency, number and duration of awakenings, final wake time, time out of bed
• Sleep environment: Bed vs. couch, light/dark, noise level, room temperature, bed partner presence, TV/screen use
• Pre-sleep state: Level of alertness (sleepy vs. wide awake), anxiety level, anticipatory worry about sleep
• Perpetuating behaviors: Time spent in bed trying to "catch up" on sleep, phone use, TV watching, eating, exercising, or clock-watching in bed 1

Daytime Consequences Assessment

Patients with chronic insomnia typically report fatigue rather than sleepiness 1. The presence of significant daytime sleepiness (actual tendency to fall asleep) should prompt investigation for other sleep disorders like sleep apnea or periodic limb movements. Document:

• Napping patterns (frequency, duration, timing, voluntary vs. involuntary)
• Mood disturbances (irritability, depression, anxiety)
• Cognitive complaints (memory, attention, complex task difficulty)
• Quality of life impact (interpersonal relationships, work performance, activity avoidance)

Critical Comorbidity Screening

Psychiatric conditions are present in 60-75% of insomnia cases and have a bidirectional relationship with insomnia 1, 2. Specifically assess for:

• Active depression, anxiety disorders, dysthymia
• Hyperalertness, stress, rumination patterns
• History of trauma or PTSD

Medical conditions that commonly cause or worsen insomnia 1:

• Chronic pain syndromes
• Cardiovascular disease (hypertension, heart failure)
• Respiratory disorders
• Endocrine disorders (diabetes, thyroid disease)
• Neurological conditions

Other sleep disorders frequently coexist 2:

• Restless legs syndrome (uncomfortable leg sensations worse at rest, relieved by movement)
• Periodic limb movements during sleep
• Sleep-disordered breathing/obstructive sleep apnea (snoring, witnessed apneas, gasping)

Medication and Substance Review

Systematically review medications and substances that disrupt sleep 1:

• Stimulants: Caffeine (timing and amount), methylphenidate, amphetamines
• Antidepressants: SSRIs, SNRIs, MAOIs
• Cardiovascular drugs: Beta-blockers, alpha-agonists/antagonists, diuretics
• Respiratory medications: Theophylline, albuterol
• Decongestants: Pseudoephedrine, phenylephrine
• Narcotic analgesics: Oxycodone, codeine
• Alcohol: Pattern and timing of use

Structured Assessment Tools

Implement sleep diaries for 1-2 weeks to establish baseline patterns 1. These should capture:

• Bedtime and rise time
• Sleep latency
• Number and duration of awakenings
• Total sleep time
• Sleep efficiency (total sleep time/time in bed × 100%)
• Naps
• Medication, caffeine, and alcohol use

Use validated questionnaires 3, 4:

• Insomnia Severity Index or Athens Insomnia Scale for symptom severity
• STOP questionnaire to screen for sleep apnea risk

When to Order Objective Testing

Polysomnography is NOT routinely indicated for uncomplicated insomnia 1, 4, 5. Order it specifically when you suspect:

• Sleep-related breathing disorders (snoring, witnessed apneas, obesity, cardiovascular disease)
• Periodic limb movement disorder or restless legs syndrome
• Treatment-resistant insomnia that fails behavioral and pharmacological interventions
• Substantial sleep state misperception (patient reports no sleep but appears rested)

Actigraphy is NOT recommended for routine insomnia evaluation but may help differentiate circadian rhythm disorders 1, 4.

Common Diagnostic Pitfalls

1. Missing psychiatric comorbidity: Since mental health conditions account for approximately 73% of insomnia cases in sleep clinics 2, failing to adequately screen for depression, anxiety, and stress-related disorders leads to treatment failure.

2. Overlooking medication-induced insomnia: Many commonly prescribed medications (SSRIs, beta-blockers, stimulants) directly cause or worsen insomnia 1.

3. Ignoring other sleep disorders: Up to 35% of insomnia patients have coexisting sleep apnea, restless legs syndrome, or periodic limb movements 2. The presence of significant daytime sleepiness (not just fatigue) is your red flag.

4. Accepting "insomnia" as the complete diagnosis: Multiple insomnia disorders and comorbidities frequently coexist and require separate identification 1.

Immediate Next Steps After Initial Evaluation

Based on your findings, the pathway diverges:

• If psychiatric comorbidity dominates (anxiety, depression, rumination): Address the mental health condition concurrently with insomnia treatment, as these have bidirectional effects 1, 2

• If other sleep disorders are suspected: Pursue appropriate testing (polysomnography for sleep apnea or periodic limb movements) before finalizing insomnia treatment 1, 5

• If primary insomnia without significant comorbidity: Proceed directly to cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment 1, 4, 5

The key is recognizing that insomnia is rarely an isolated condition—your initial evaluation must systematically uncover the contributing and perpetuating factors that will guide treatment selection 1.